Pfizer Korea to appeal Viagra case

Published: 2012-06-01 06:58:00

Updated: 2012-06-01 06:58:00

Pfizer Korea said today it is considering filing an appeal with the Patent Court against the Korea Intellectual Property Tribunal’s ruling in favor of CJ Pharma and several other companies over the nullification of its main patent for Viagra on Wednesday.

“We are very disappointed with the cou...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK